Structure of the membrane proximal oxidoreductase domain of human Steap3, the dominant ferrireductase of the erythroid transferrin cycle

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 21, 2008, Pages 7410-7415

  Sendamarai, Anoop K ^a   Ohgami, Robert S ^b   Fleming, Mark D ^b   Lawrence, C Martin ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Erythrocyte; Ferric; Iron transport

Indexed keywords

HEME; IRON REDUCTASE; MEMBRANE PROTEIN; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SIX TRANSMEMBRANE EPITHELIAL ANTIGEN OF THE PROSTATE 3; FERRIC CITRATE IRON REDUCTASE; FLAVINE MONONUCLEOTIDE REDUCTASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; ONCOPROTEIN; TRANSFERRIN; TSAP6 PROTEIN, HUMAN;

ARTICLE; BINDING SITE; CHANNEL GATING; CRYSTAL STRUCTURE; CYTOSOL; ELECTRON TRANSPORT; ENDOSOME; ERYTHROCYTE; ERYTHROID TRANSFERRIN CYCLE; HUMAN; IRON TRANSPORT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; CHEMISTRY; CRYSTALLOGRAPHY; DIMERIZATION; ELECTRICITY; ENZYMOLOGY; ERYTHROID PRECURSOR CELL; PROTEIN TERTIARY STRUCTURE;

ARCHAEA; EUKARYOTA;

BINDING SITES; CRYSTALLOGRAPHY; DIMERIZATION; ELECTROSTATICS; ERYTHROID PROGENITOR CELLS; FMN REDUCTASE; HUMANS; NADP; ONCOGENE PROTEINS; OXIDOREDUCTASES; PROTEIN STRUCTURE, TERTIARY; TRANSFERRIN;

EID: 44949136325     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0801318105     Document Type: Article

References (39)

1. Gutteridge JM, Rowley DA, Halliwell B (1981) Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of "free" iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem J 199:263-265.
2. Andrews NC (1999) Disorders of iron metabolism. N Engl J Med 341:1986-1995.
3. Grosbois B, Decaux O, Cador B, Cazalets C, Jego P (2005) [Human iron deficiency]. Bull Acad Natl Med 189:1649-1663; discussion 1663-1664.
4. Hentze MW, Muckenthaler MU, Andrews NC (2004) Balancing acts: Molecular control of mammalian iron metabolism. Cell 117:285-297.
5. Pietrangelo A (2004) Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 350:2383-2397.
6. Pietrangelo A (2004) Non-HFE hemochromatosis. Hepatology 39:21-29.
7. Beutler E (2003) The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. Blood 101:3347-3350.
8. Whitlock EP, Garlitz BA, Harris EL, Beil TL, Smith PR (2006) Screening for hereditary hemochromatosis: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 145:209-223.
9. Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M (2005) Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci USA 102:1324-1328.
10. Richardson DR, Ponka P (1997) The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta 1331:1-40.
11. Ohgami RS, et al. (2005) nm1054: A spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. Blood 106:3625-3631.
12. Ohgami RS, et al. (2005) Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet 37:1264-1269.
13. Ohgami RS, Campagna DR, McDonald A, Fleming MD (2006) The Steap proteins are metalloreductases. Blood 108:1388-1394.
14. Sanchez-Pulido L, Rojas AM, Valencia A, Martinez AC, Andrade MA (2004) ACRATA: A novel electron transfer domain associated to apoptosis and cancer. BMC Cancer 4:98.
15. Alves PM, et al. (2006) STEAP, a prostate tumor antigen, is a target of human CD8+ T cells. Cancer Immunol Immunother 55:1515-1523.
16. Hubert RS, et al. (1999) STEAP: A prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci USA 96:14523-14528.
17. Challita-Eid PM, et al. (2007) Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo. Cancer Res 67:5798-5805.
18. Garcia-Hernandez Mde L, Gray A, Hubby B, Kast WM (2007) In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: A candidate antigen for treating prostate cancer. Cancer Res 67:1344-1351.
19. Kobayashi H, et al. (2007) Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner. Cancer Res 67:5498-5504.
20. Wellen KE, et al. (2007) Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell 129:537-548.
21. Waki H, Tontonoz P (2007) STAMPing out inflammation. Cell 129:451-452.
22. Nath D, Heemels M-T, Anson L (2006) Obesity and diabetes. Nature 444:839.
23. + oxidoreductase with and without its substrates bound. EMBO J 20:6561-6569.
24. Krissinel E, Henrick K (2004) Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D 60:2256-2268.
25. Torres RA, Bruice TC (1999) Theoretical investigation of the [1,2]-sigmatropic hydrogen migration in the mechanism of oxidation of 2-aminobenzoyl-CoA by 2-aminobenzoyl-CoA monooxygenase/reductase. Proc Natl Acad Sci USA 96:14748-14752.
26. Pereira PJ, et al. (2001) Structure of human biliverdin IXbeta reductase, an early fetal bilirubin IXbeta producing enzyme. Nat Struct Biol 8:215-220.
27. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
28. Otwinowski Z, Minor W (1997). Processing of X-ray diffraction data collected in oscillation mode. Macromolecular Crystallography, Part A, Carter C, Sweet R, eds (Academic, New York) Vol. 276, pp 307-326.
29. Terwilliger TC, Berendzen J (1999). Automated MAD and MIR structure solution. Acta Crystallogr D 55:849-861.
30. Terwilliger TC (2000). Maximum likelihood density modification. Acta Crystallogr D 56:965-972.
31. Terwilliger TC (2002). Automated main-chain model-building by template-matching and iterative fragment extension. Acta Crystallogr D 59:34-44.
32. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr D 60:2126-2132.
33. Bailey S (1994). The CCP4 suite - programs for protein crystallography. Acta Crystallogr D 50:760-763.
34. Murshudov GN, Vagin AA, Dodson EJ (1997). Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D 53:240-255.
35. Winn MD, Murshudov GN, Papiz MZ (2003) Macromolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol 374:300-321.
36. Painter J, Merritt EA (2006) TLSMD web server for the generation of multi-group TLS models. J Appl Crystallogr 39:109-111.
37. Painter J, Merritt EA (2006) Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr D 62:439-450.
38. Davis IW, et al. (2007) MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35:W375-W383.
39. DeLano WL (2002). The PyMOL Molecular Graphics System. Available at www.pymol.org.